Tag: Senseonics
FDA Issues Recall for Eversense Continuous Glucose Monitoring System
The US Food and Drug Administration (FDA) has issued a recall for Senseonics’ Eversense Continuous Glucose Monitoring (CGM) system.
Read more Senseonics & Glooko Partner...
Senseonics Gets FDA Approval for Eversense Implantable CGM System
Senseonics, a company that develops implantable continuous glucose monitoring (CGM) system for people with diabetes, received FDA approval for the non-adjunctive indication (dosing claim)...
Senseonics’ New Program Geared Towards Patients with High-Deductible Insurance Plans
Senseonics, a company well-known for its continuous glucose
monitoring (CGM) system announced a new program called Eversense Bridge for patients
who carry a high-deductible insurance plans...
Senseonics & Glooko Partner Up for Integrated Diabetes Management
Senseonics, the maker of Eversense, the world’s first long-term CGM system, announced the integration of Eversense CGM data into the Glooko diabetes data management...
Senseonics’ Eversense Now Receiving Coverage from Aetna
Senseonics, a Germantown, Maryland-based medtech startup developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that Aetna, the third largest...
The Diabetes Epidemic is Driving Med Tech Companies to Develop Wearable Devices to Manage...
Sedentary lifestyle and obesity are triggering a rise in the number of diabetes cases. The complex process of diabetes management often requires a multidisciplinary...